WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

Proposed new classification for L01XE Protein kinase inhibitors and L01XX Other antineoplastic agents
Published Monday December 2 2019

Proposed new classification of L01XE Protein kinase inhibitors and L01XX Other antineoplastic agents. Deadline for comments 1 February 2020. See information regarding the proposal here.

Archive

04.12.19
02.12.19
29.11.19
29.11.19
12.11.19
02.05.19
02.05.19
18.12.18
13.12.18
26.11.18
21.11.18
17.10.18
15.05.18
15.05.18
23.02.18
22.12.17
29.11.17
28.11.17
09.05.17
09.05.17
21.02.17
15.12.16
05.12.16
02.11.16
19.05.16
22.01.16
18.12.15
09.12.15
09.12.15
08.12.15
02.12.15
28.10.15
05.05.15
30.04.15
16.12.14

Last updated: 2019-12-05